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palavras-chave 
 
Inativação fotodinâmica de microrganismos (PDI), ftalocianinas, bactérias, 
Escherichia coli, bioluminescência, biofilmes 
resumo 
 
 
O objetivo deste trabalho foi sintetizar e caracterizar novas ftalocianinas (Pc) 
para serem testadas na inativação fotodinâmica de microrganismos. Nesse 
sentido tentou-se obter uma nova família de ftalocianinas de zinco(II) tetra e 
octa-substituídas nas posições periféricas. Os compostos foram caracterizados 
através de espectrometria de massa e espetroscopia de RMN. Foi avaliada a 
eficiência de inativação de seis zinco(II)Pc tetra- octa- e hexadeca- substituídas 
com  grupos DMAP numa estirpe de Escherichia coli recombinante 
bioluminescente na sua forma planctónica. Os ensaios foram realizados a uma 
concentração de 20 µM de fotossensibilizador e luzes vermelha e branca com 
uma potência de 150 mW cm-2, como fontes de irradiação. Foram ainda 
realizados ensaios de inativação fotodinâmica de biofilmes da mesma estirpe 
bacteriana usando a luz vermelha e os PS que apresentaram melhores 
resultados nos ensaios com a forma planctónica. Foram também realizados 
testes de geração de 1O2, solubilidade, rendimento quântico de fluorescência, 
fotoestabilidade, estabilidade e uptake com as ZnPcDMAP. 
As Pc 4 e 5 apresentaram maior eficiência na inativação de E. coli na sua forma 
livre, causando reduções de 4 log na bioluminescência da bactéria. Contudo, 
mostraram reduzida eficiência na inativação fotodinâmica de biofilmes, 
causando reduções de apenas 2 log na bioluminescência. Em conclusão, Pc 4 
e 5 são fotossensibilizadores promissores para a inativação fotodinâmica de E. 
coli na forma livre. No entanto, ainda é preciso encontrar as condições ideais 
para inativação mais eficiente de biofilmes. 
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abstract 
 
 
 
 
 
 
 
 
 
 
 
The main goal of this work was to synthesize and characterize new 
phthalocyanines (Pc) for the photodynamic inactivation of microorganisms. For 
this, the synthesis of a new family of zinc(II)Pc tetra- and octa- substituted at the 
peripheral positions was attempt. The compounds were characterized by mass 
spectrometry and NMR spectroscopy. The inactivation efficiency of six Zinc(II) 
Pc, tetra- octa- and hexadeca-substituted with DMAP groups was evaluated 
against a recombinant bioluminescent strain of Escherichia coli in its planktonic 
form. The experiments were carried out at a concentration of 20 μM of 
photosensitizer, and either red or white light, with a fluency rate of 150 mW cm-2 
as energy source. Assays of photodynamic inactivation of biofilms of the 
bioluminescent strain were also conducted with red light and the PS that 
demonstrated better performance in the photodynamic inactivation of free cells. 
The generation of 1O2, the solubility, fluorescence quantum yield, photostability 
and cellular uptake were also assessed. Pc 4 and 5 presented the highest 
inactivation efficiency in the planktonic form of the bioluminescent E.coli, causing 
reductions of 4 log in their light emission. These molecules were however much 
less effective against biofilms of the same strain, causing reductions of 
approximately 2 log in the light emission. In conclusion, Pc 4 and 5 are promising 
photosensitizers for the photodynamic inactivation of planktonic E.coli, but it still 
necessary to find ideal conditions for the efficient inactivation of biofilms.  
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     Chapter 1-Introduction 
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1.1.  The photodynamic effect 
Light has been used to treat diseases since ancient civilizations like the Egyptian, Chinese and 
Indian. Individuals afflicted by particular conditions, like vitiligo, would ingest plants and 
expose themselves to solar light to mitigate the symptoms of the disease. In ancient Greece this 
treatment was designated as heliotheraphy.1 In 1901, after demonstrating that solar light could 
be used to treat lupus vulgaris, Niels Finsen introduced for the first time the term phototherapy.2 
Later, in 1904, Herman von Tappeiner and Jodlbauer verified that oxygen had to be present to 
destroy protozoa paramecium with light in presence of acridine orange, using the term 
photodynamic effect to describe the process.3 
 
1.1.1.  Mechanisms 
The photophysical processes underlying the photodynamic inactivation occur when the 
photosensitizer absorbs light in an appropriated wavelength and the electrons are transferred 
from its singlet ground state (S0) to its first excited singlet-state (S1). This singlet state, S1, has a 
short-lifetime and because of this the PS tends to return to the ground state by relaxation emitting 
the light absorbed as fluorescence or by internal conversion. Also, the relaxation to the S0 state 
can occur by another pathway called intersystem crossing. This phenomenon takes place when 
the first excited state electrons reach to S0 state, the electrons of the PS are transferred to an 
intermediate state called first excited triplet state (T1) and then can decay to the S0 by 
phosphorescence. The energy transferred from T1 to biological substrates or molecular oxygen 
will generate singlet oxygen or the other reactive oxygen species (ROS), leading to cell 
inactivation.4 For a photosensitizer to be considered a good singlet oxygen generator it must be 
able to go through this pathway with high efficiency.5 The photo-physical and chemical 
mechanism is illustrated in Figure 1.  
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The PDI process can occur mainly by two types of photochemical pathways, designated as type 
I and type II pathways, wherein all of them result in oxidation of biomolecules present in the 
cells leading to cell death. In the type I pathway, the photosensitizers in its excited state generate 
radical species by transferring electrons to a substrate or by capturing hydrogen atoms from it. 
This type of mechanism can occur when electrons are transferred from the excited 
photosensitizer to triplet oxygen forming superoxide (Scheme 1). The later one can suffer 
dismutation to hydrogen peroxide that is a toxic substance causing cell damage. In the type II 
pathway the electron transference occurs between the T1 photosensitizer and the triplet ground 
state of molecular oxygen, leading to the production of singlet oxygen (Scheme 2). The most 
common mechanism in the photodynamic inactivation of cells is the type II mechanism. 5,6 
 
Figure 1 - Jablonski diagram describing the mechanisms involved in the production of singlet 
oxygen: where E is energy, 1) absorption, 2) fluorescence, 3) internal conversion, 4) intersystem 
crossing, 5) phosphorescence, 6) formation of free radicals (R).4 
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Scheme 1-  Schematic representation of type I mechanism5 
 
Scheme 2-  Schematic representation of type II mechanism5 
 
 
 
1.1.2.  Light Sources 
The sun was the first light source used in photodynamic therapy, and although it may be the 
most suitable light source for environmental applications, it was not ideal for treatments with 
selective wavelengths and it was necessary to focus the light in the region to be treated.7 New 
sources had to be developed for clinical photodynamic therapy (PDT). Initially, PDT was 
performed with xenon arc lamps and slides projectors with red filters to eliminate short 
wavelengths. Although the conventional lamps were inexpensive, simple and safe to use, they 
were not the best alternative because of the thermal effect, the low light intensity and difficulty 
to control light dose. Light-emitting diodes (LED) were also used because they could generate 
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high-energy light of desired wavelength and could be assembled in a range of geometries and 
sizes. Other commonly used light sources are lasers, such as argon dye, potassium–titanium–
phosphate (KTP) dye, metal vapour lasers and diode lasers.8,9 Comparing solar light with 
artificial lamps, depending on the power supply/ lamp, the second ones can provide higher 
fluency rates.10,11 However, it should be taken into account that when high fluency are used the 
PS cannot absorb all photons, and for the photodynamic inactivation occur the absorption 
spectrum of the PS must have a good adjustment with the emission spectra of the light 
source.12,13 
The range of wavelengths that is normally used in photodynamic inactivation of microrganisms 
is between 300-800 nm and in PDT is between 650-800 nm.14 Normally, at the longer 
wavelengths deeper penetration of the radiation and better efficiency of inactivation are 
achieved. Thus, the development of PS that absorb at longer wavelengths, such as 
phthalocyanines, naphthalocyanine and bacteriochlorins, in order to get greater efficiency of 
photodynamic inactivation, is a major challenge for the scientists.15 
Many PS are prone to photo-destruction by photobleaching, when upon illumination, the free 
radical reacts with the PS leading to reduction of its efficiency for further photosensitization 
effect, and loss of absorbance.15 
 
1.1.3.  Oxygen and reactive species 
A highly reactive oxygen species, singlet oxygen (1O2), was found to play an important role in 
biological systems. For example, it was associated to antibacterial or antimicrobial agent and 
with cell death in the PDT therapeutic processes.16 
In the photodynamic inactivation process, singlet oxygen is produced by electronic energy 
transfer from the excited state of a sensitizer to molecular oxygen.16  It can be generated by wide 
range of heterocyclic aromatic compounds and it has a short life time, of about 200 ns.17,18 When 
1O2 is produced inside or very close to the cells, it will interact with different intracellular 
molecules, depending on the site of generation. This will influence the responses of the cell, i.e. 
depending on site of production, different responses are triggered by the cells. 
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It has been suggested that in bacteria and eukaryotic cells, cytoplasmic membrane is the main 
site of lethal damage via photosensitization and singlet oxygen. However, other intracellular 
molecules can also be vital targets for this toxic agent.19 When penetration of 1O2 is limited by 
the outer membrane, such as in case of Gram-negative bacteria, secondary products are 
generated by the reaction of 1O2 with the membrane, which plays a role as additional toxic 
species contributing to further destabilize the membrane and ultimately enhance the penetration 
of singlet oxygen.20 
The photodynamic inactivation of cells is widely influenced by the photochemical yield of the 
1O2 and this depends on the intrinsic characteristic of the PS. PS that present tendency to 
aggregate with increasing of concentrations, results in lower singlet oxygen quantum yields.6 
To monitor the capacity of PS to generate singlet oxygen, it can be used direct or indirect 
methods.  The determination of 1O2 luminescence by near-infra-red (NIR) emission method has 
been used for direct quantification of 1O2 life-time and quantum yield. The production of 
1O2 
can be qualitatively measured by the indirect methods of p-nitrosodimethylalanine and 1,3-
diphenylisobenzofuran (DPBF). In the DPBF method the production of 1O2 is proportional to 
the loss of absorbance of DPBF, because the reaction of 1O2 with the coloured acceptor DPBF 
leads to formation of the uncoloured compound o-dibenzoylbenzene.21 
 
1.1.4.  Photosensitizers 
Photosensitizers are natural or synthetic organic compounds that when excited by a specific 
wavelength have the ability to absorb light and transform it into energy, to induce reaction in 
other molecules, that ultimately will lead to damage on biological targets.22 
In 1960, Lipson and Schartz discovered a photosensitizer that was named as hematoporphyrin 
(HPD). Few years later, this compound was partially purified, made available under the 
commercial name of Photofrin® and used to treat several types of cancer.22 This is considered 
the first generation of photosensitizers and since then, new generations of PS, second and third 
generations, were developed with different characteristics and for different applications. The 
second generation PS include, texaphyrins, phthalocyanines, chlorin e6; benzoporphyrin 
derivative (BPD) and bacterioclorophyll. The third generation PSs correspond to conjugates of 
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second generation PS coupled with antibodies.23 The first generation of PS are characterized by 
weak absorption at red wavelength region, while the second generation of PS have very strong 
absorption at those wavelengths. In third generation the antibodies are coupled to the PS in order 
to transport the photosensitizer to target cells.23 
The efficiency of the PS depend on its properties and on the intended application.24 In the case 
of photodynamic inactivation of microorganisms, the PS should ideally present the following 
characteristics:  
 
 Active against several groups of microorganisms;  
 Low toxicity in the absence of light and cytotoxic only when excited with light of defined 
wavelength;  
 High extinction coefficients, particularly at long wavelength, for deep tissue penetration 
of light;  
 High triplet and singlet oxygen quantum yield;  
 Preferential retention by target cells.25 
For the photodynamic inactivation of microorganisms, both in the planktonic and sessile forms, 
compounds such as chlorines, bacteriochlorins, phenothiazines, porphyrins and phthalocyanines 
have been tested. 26–28  
Some examples of PS used in the photodynamic inactivation of bacteria in planktonic and 
biofilm forms are represented in Table 1. 
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Table 1 - Example of photosensitizers used in photodynamic inactivation of bacteria in planktonic and biofilm 
forms (extracted from the review by Almeida et al., 2011).29 
Photosensitizer Planktonic cells Biofilms 
Hematoporphyrin 
 
Bacillus subtilis, Streptococcus fecalis, 
Pseudomonas 
aureginosa,staphilococcus aureus 
Micrococcus luteus, Escherichia coli, 
Proteus vulgaris, Klebsiella 
pneumonia, Enterobacter clocae, 
Serratia marcescens, Bacillus cereus 
Phorphyromonas 
gengivalis,Fusobacterium 
nucleatum,Streptococcusnsanguinis, 
Actinomyce actinomycetemcomitans 
Chlorin derivatives 
 
Porphyromonas gingivalis, 
Actinomyces actinomycetemcomitans, 
Actinomyces viscosis, Escherichia coli, 
Bacillus subtilis, Staphylococcus 
aureus, Pseudomonas aeruginosa, 
Fusobacterium nucleaum, 
Streptoccocci 
Porphyromonas gingivaliss, 
Actinomyces viscosis, 
Actinomycesnaeslundi  
Porphyrin 
 
Escherichia coli, Staphylococus aureus, 
Vibrio auguillarum, Entereococus 
seriolicida, Ainobacter baumannii, 
Diendococcus radiodurans, Yersinia 
enterocolitica, Mycobacterium 
smegmatis, Fecal coliformes, 
Pseudomonas aureginosa, 
Staphylococcus epidermais, 
Entereococcus fecatis, Bacillus subtilis, 
Prevotella intermedia, 
Propionibacterium acnes, 
Porphyromonas gingivalis 
Provotella intermedia, 
Propinobacteruim acnes, Streptococcus 
mutans, Porphyromonas gingivalis, 
Actinomyces odontolyticus 
ALA 
 
Haemophilus parainfluenzae, 
Staphylococcus epidermidis, 
Staphylococcus aureus, Escherichia 
coli, Enterococcus hirae, 
Propinobacterium acnes, Bacillus 
cereus, Staphylococcus strains, 
Salmonella enteric, Proteobacterium 
acnes 
Pseudomonas aeruginosa 
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1.1.4.1. Phthalocyanines (Pc) 
Phthalocyanines are blue coloured photosensitizers with a planar aromatic macrocycle structure 
and with high chemical and thermal stability, which make them widely used in industries.30,31 
The name phthalocyanine comes from the Greek words naphtha (rock oil) and cyanine (dark 
blue).  
Phthalocyanines were first discovered in 1907 by Braun and Tcherniak during experiments with 
o-cyanobenzamide.32 In their studies, they found that when this compound was heated, a blue 
coloured solid was obtained. This product was a metal-free compound and therefore it was 
identified as a metal-free phthalocyanine.32 In 1927, Diesbach and co-workers described for the 
first time a synthetic route to obtain phthalocyanines from 1,2-dibromobenzene. They found that 
1,2-dibromobenzene when treated with copper(I)cyanide in boiling quinoline for eight hour 
results in a blue product. This was the first time that a copper phthalocyanine (CuPc) was 
synthesized; however, they were not able to describe the structure of the compound. In 1928, a 
new metal-phthalocyanine was discovered by a Scottish dye company from the reaction of 
phthalic anhydride with ammonia, in a glass-lined reactor. This new compound was identified 
as an iron (III) phthalocyanine (FePc). Although the synthetic routes for Pc had been described, 
the structure was only unrevealed in 1933 by Linstead, with the analysis of metal 
phthalocyanines and products from degradations, and later confirmed by Robertson by X-ray 
crystallography.32 
The structure of the phthalocyanines is similar to that of porphyrins and therefore, Pc are also 
known as tetra-azaporphyrins. The molecular structure of a Pc consists in four isoindole units 
linked by aza nitrogen atoms, whereas porphyrins are composed by four pyrrole units linked by 
methylene carbon bridges. The isoindole units of the Pc present 18 π-electrons delocalized over 
an arrangement of carbon and nitrogen atoms (Figure 2).1,30  
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Figure 2- Molecular structure of free-base phthalocyanine (Pc) 
 
The phthalocyanine derivatives are molecules with interesting optical properties both in near 
visible and near infrared (NIR) region, intense bright colour, high thermal and chemical stability 
and strong delocalized structure. Because of these features, the Pc has received a great attention 
in different areas, such as in textile industry, photography, electronic industry and photodynamic 
therapy.32,33 
The phthalocyanines show two strong and well-resolved bands in their absorption spectra the Q 
band and the B band (Soret band) (Figure 3). The most intense band is the Q band that lies 
within the visible region at the wavelengths between 650-700 nm and less intense one is the B 
band that lies at the ultraviolet region at 340 nm. The capacity to absorb in the red region confers 
the characteristic colours of these compounds. However, the intensity of the colour can be 
slightly varied by introduction of metal in the central core of the Pc.32 
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Figure 3 - Absorption spectra of a metal-free-phthalocyanine (solid line) and a metal-phthalocyanine (dotted 
line).34 
 
In the absorption spectra of the metal-free Pc two Q-bands peaks are observed whereas the metal 
Pc shows a single Q-band peak in the red region. This happens because of the differences of 
symmetry in these two types of Pc.35 In the metal-free phthalocyanines, two of the isoindole 
nitrogen are carry hydrogen atoms and the other two are involved in iminic type functions. Thus, 
in later, the Q-band is split in two components whereas in the metal Pc, the incorporation of a 
metal ion inside the central cavity affects the system in a way that a thermodynamically stable 
delocalized dianion with higher symmetry is obtained. However, this is only observed for 
symmetrical substituted Pc. If the periphery is asymmetrically substituted, a split Q-band will 
appear. In addition, the position of Q band and B bands can also be affected by the nature of the 
metal introduced in macrocycle. The variation arises due to decrease of co-extinction coefficient 
of both bands upon metal introduction.35 
 
On the PDI field, the phthalocyanines are regarded with great interest because of their ability to 
absorb in the red region, 600-700 nm, and because they are very efficient producers of singlet 
oxygen.30 The capacity to absorb light with long wavelength is a very important attribute in PS 
for clinical application, because it allows a deeper penetration treatment on target tissue or 
cells.33  However, Pc molecules have the tendency to form dimmers and aggregates, what leads 
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to lower photodynamic inactivation efficiency. Aggregation can cause insolubility in many 
solvents and reduces the lifetime of the PS excited state, causing low quantum yields of excited 
states and of singlet oxygen generation. Aggregation phenomena can be detected from the 
absorption/emission spectra of the molecules.36 
 
Phthalocyanines are compounds with high chemical flexibility and thus, the preparation of 
analogous Pc with better physical, electronic and optical properties is possible. 
The two hydrogen atoms in the central core of the Pc can be replaced by 70 types of different 
metals, leading to the formation of metal-phthalocyanines with additional features and 
optimized physical responses.35 In addition to changes in the core of the macrocycle, it is also 
possible to make substitutions on the peripheral positions. The substitutions that are introduced 
in peripheral position are known as β- and α-substitutions. 
According to IUPAC nomenclature, the Pc macrocycle is numbered, wherein the position 1, 4, 
8, 11, 15, 18, 22 and 25 correspond to the α-position and the 2, 3, 9, 16, 17, 23 and 24 to the β-
positions (Figure 4).37 Accordingly, various types of functional groups and molecules can be 
refereed as substituents at α or β positions. 
 
 
Figure 4- Molecular structure of a metalo-phthalocyanine (MPc) and a metal-free-phthalocyanine 
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The introduction of substituents on the molecule may considerably change its properties. For 
instance, in order to improve the solubility, as well as the optical and redox properties, alkyl or 
bulky groups can be introduced in the peripheral positions of the macrocycle.31 
 
The peripheral substitutions can affect the Q-band. The substitutions in those positions can be 
carried out with electron-puller or electron-donating groups and depending on which group is 
introduced, different variations on its Q-band peaks can be observed. It is known that the β-
substitutions with electron-pullers tend to cause a shift of the Q-band to the red region of the 
visible spectrum while the substitution with electron-donating groups do not affect strongly the 
Pc Q-band absorption maxima. The α-substitutions are known to cause stronger effects in the 
absorption spectra when compared with β- substitutions. However, the effect caused by the 
substitutions in the absorption spectra depends on each particular substituent and on the number 
of substituents.35 
 
1.1.4.2.  Synthesis of phthalocyanines  
The synthesis of unsubstituted/substituted metal-free phthalocyanines (H2Pc) and metal-
phthalocyanines (MPc) can be carried out through different methodologies and different 
precursors. The most common precursors used to obtain Pc are the phthalyl derivatives, 
phthalonitriles or 1,3-diiminoisoindoline and normally Pc is accomplished through the 
cyclotetramerization of one of these precursors.38,39 
For the synthesis of H2Pc the most common precursor used is the phthalonitrile, which by its 
cyclotetramerization will give rise to a new Pc. For the cyclotetramerization to occur, initially 
it is necessary the formation of a diiminoisoindoline through the reaction of the phthalonitrile 
with one salt, after this the diiminoisoindoline will condense in appropriate conditions and H2Pc 
will be formed.37 
The synthesis of MPc can be done using precursors as phthalonitriles; diiminoisoindoline; 
phthalic anhydride or phthalamide, being the phthalonitriles the most common. In the case of 
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MPc synthesis the cyclotetramerization is carried out through the reaction of the precursor with 
metal salt and a nitrogen source such as urea (Figure 5). Another alternative to obtain MPc is 
through the reaction of H2Pc or LiPc with an appropriate metal salt. For the complete metallation 
of the phthalocyanine an aromatic solvent such as 1-chloronaphthalene or quinine has to be 
added to the reaction.37 
 
Figure 5 - Synthetic routs for metal-phthalocyanine synthesis 
 
An alternative to obtain substituted phthalocyanines is the previous introduction of substituents 
groups in the precursor followed by their cyclotetramerization.23 
The tetra-substituted phthalocyanines prepared from four identical precursor lead to a mixture 
of four isomers with different symmetries, D2h, C4h, C2v and Cs (Figure 6). This mixture contains 
12.5% of D2h isomer, 12.5% of C4h isomer, 25% of C2v isomer and 50% of Cs isomer. In addition 
there is two types of tetra-substituted Pc, β and α substituted Pc. The β substituted can be 
obtained from 4 substituted phthalonitriles whereas the α substituted is obtained from 3-
substituted phthalonitriles.39 The octa-substituted phthalocyanines can be synthesized by a 
cyclotetramerization reaction, where 3,6 and 4,5-disubstituted phthalonitriles will produce octa-
substituted Pc.37 
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Figure 6 - The possible regiosomers of tetra-substituted phthalocyanine derivatives 
The synthesis of substituted Pc can be also done by a nucleophilic substitution of an existing 
phthalocyanine. One example is the nucleophilic substitution of fluorine atoms in the 
hexadecafluorinated zinc phthalocyanine (ZnPcF16), ZnPc analogue, by other atoms or 
molecular groups. These reactions are considered a rapid way to obtain phthalocyanine. In the 
case of ZnPcF16 the fluorine is an excellent leaving group what facilitates the replacement. In 
addition, this molecule presents different reactivity of the fluorine groups in α and β positions 
and because of this it is easier to obtain octa-substituted Pc since that the β fluorine atoms are 
more reactive than the α fluorine. For the octa-substituted Pc the remaining fluorine atoms 
constitute a major advantage since that they can protect the chromophore from oxidation. Beside 
this the fluorine atoms confers to the molecule thermal stability.40,41 
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1.2.  Photodynamic inactivation of microorganisms 
The concept of PDT dates back to when the research group of Oscar Raab from Tappeiner used 
eosin, together with light, to treat skin cancer. Although initially used in the treatment of cancer, 
Oscar Raab also observed the toxic effects of acridine hydrochloride on Paramecia caudatum. 
After these developments, studies were pursued by other investigators. The inactivation of 
Proteus vulgaris was demonstrated and oxygen was identified as an essential requirement for 
the antimicrobial activity of fluorescent dyes.26 In the context of anti-microbial approaches, the 
concept, photodynamic inactivation (PDI) was established as the inactivation or limitation of 
growth of microorganisms throught photodynamic effectt.26 
The PDI of microorganism requires the interaction between three elements: a photosensitizer 
(PS), light and molecular oxygen.  Individually, they are non-toxic agents but when combined 
they will cause lethal damages.42 
The photosensitizer, localized in the target cells, when activated by low doses of visible light of 
appropriate wavelength, will induce photochemical activation of molecular oxygen into its 
triplet state, singlet oxygen or other oxygen reactive species (ROS). Singlet oxygen is extremely 
toxic to cells because there is no efficient cellular mechanism of defence or detoxification 
against this oxygen specie. The targets of the cytotoxic effect are biological molecules such as: 
proteins, nucleic acids and lipids, and the damage is exerted by oxidation reactions.19,43–45   
In order to get an efficient PDI or a complete inactivation of the target microorganism some 
requirements must be fulfilled during the photosensitization process: 
 
 Efficient adsorption (uptake) of the PS by the microorganism  
 Lack of induction of resistance responses upon multiple treatments 
 Low toxicity in comparison with other anti-microbial agents. 
 
The PDI approach can be  used to inactivate undesired microorganisms in different contexts and 
it has been gaining interest for environmental applications such as the disinfection of water or 
wastewater.24,46 It is also envisaged for clinical applications, namely to treat infections caused 
by microorganisms that are becoming less susceptible to current antibiotics. In this case, the 
method is known as photodynamic antimicrobial chemotherapy (PACT).24 In the clinical field, 
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PDT is used not only to treat infection but still, and actually since longer, to treat tumours instead 
of the traditional methods like surgery, radiotherapy and chemotherapy.47 
 
 
1.2.1.  Photodynamic inactivation of bacteria 
PDI has proved to be an efficient way to inactivate different groups of microorganisms such as 
virus, bacteria and fungi. However, there are considerable variations in the susceptibility of 
different microorganisms. For instance, Gram-positive and Gram-negative bacteria are not 
equally susceptible to the photodynamic inactivation process. It is known that neutral and 
anionic PS are very efficient against Gram-positive bacteria, but not against Gram-negative 
bacteria. The latter are more resistant to such PS. This difference is due to structural differences 
of the cell wall of these microorganisms.14 The high susceptibility of Gram-positive bacteria can 
be explained by the fact of having a membrane that is surrounded only by a layer of 
peptidoglycan allowing the PS to cross the cell wall and reach the cell membrane.46 The Gram- 
negative cell wall has a more complex constitution, with a lipid bilayer outer membrane, 
periplasm and peptidoglycan layer. The outer membrane represents an additional barrier for the 
PS and generally, neutral or anionic PS that can efficiently bound to Gram-positive cell wall 
and mediate PDI, do not efficiently bind to the Gram-negative cell wall.48,49 For the occurrence 
of photodynamic inactivation of Gram-negative bacteria, neutral or anionic PS must be 
combined with other biological molecules, such as nona-peptide polimyxine B or 
ethylenediamine tetra-acetic acid (EDTA), which will act as outer membrane disorganizing 
substances. These molecules allow the inactivation because they will increase the permeability 
of Gram-negative outer membrane so that the PS can penetrate to locations where the oxidative 
species (ROS) will cause a fatal damage to the cell.48 Nevertheless, it is also now possible to 
perform the direct inactivation of Gram-negative bacteria using cationic photosensitizers, such 
as Zn-phthalocyanines, meso substituted cationic porphyrins and poly-L-lysine substituted 
chlorine e6, etc.50–52 These cationic photosensitizers bind to the Gram-negative bacteria surface 
and their polycationic nature allow the penetration through the outer membrane by disturbing 
the lipopolysaccharide layer.52  These PS can bind more easily to the outer membrane due to 
enhancement of electrostatic interactions between the positive charge of the PS and negative 
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charges in the bacteria membrane.53,54 Therefore, primary damage of the cell wall occurs and 
then the penetration of PS is achieved.27 
Other factors can also influence the difference in PDI susceptibility of different bacteria groups, 
such as differences in antioxidant enzymes, DNA repair mechanisms or number of microbial 
cell.52,55 
 
1.2.2.  Photodynamic inactivation of biofilms 
 
1.2.2.1.  Biofilms structure and physiology 
Many microorganisms can occur in nature aggregated or physically attached to surfaces or 
environmental interfaces in the form of biofilms and are more frequently found in this form in 
nature.56 To form a biofilm, bacteria transit from a planktonic stage to a sessile stage. Once in 
this stage the biofilm is formed and it will be protected by an extracellular polysaccharide matrix 
produced by the microorganisms.57 Biofilms can be described briefly as a community of 
microorganisms that form an assembly with a complex structure capable of attaching to surfaces 
and interfaces.58 
Biofilms represent an advantageous lifestyle because surfaces tend to concentrate nutrients and 
by attaching, bacteria are better provided with substrates, become less affected by changes in 
environmental conditions, and display enhanced resistance to many antimicrobial agents and to 
host defenses.59–62 Once organized in a biofilm, the microorganisms will be express 
characteristics that may be different from those exhibited by the planktonic forms due to changes 
in general  physiology, metabolism, and gene expression.63   
Biofilms can be found on various microhabitats: natural environments and inert surfaces, living 
tissues (e.g. plant roots, intestinal tracts), medical devices (e.g. pacemakers, catheters, dental 
plaque), industrial equipment (pipelines), and they can occur in solid-liquid, solid-air and in 
liquid interfaces.57,64,65 
To form a biofilm, the microorganisms will only select the environment that provides them 
better conditions to grow according to chemical and physical signals detected from the 
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environment. When the right conditions are not met, the biofilm will disassociate into individual 
cell that will seek a new favorable habitat.59,66 The transition from the swimming form to the 
sessile form depend on the microorganism species, environmental factors and on particular 
genetic determinants. The processes involve five distinct fundamental steps: pre-conditioning 
of the adhesion surface; attachment of microorganisms; microcolony formation; macrocolony 
development and dispersal (Figure 7).67 
 
Figure 7 – Process of biofilm formation67 
 
Normally, the attachment is divided into two stages, one reversible and other irreversible, given 
that the first attachment is weak and it can be easily reverted by fluid shear forces.60 In the first 
stage, a planktonic organism is transported nearby the surface to initiate adherence and for this 
some physicochemical variables are needed. Once close enough to the surface, the 
microorganism will bind to it, in response to a net of attractive or repulsive forces. These forces 
include electrostatic and hydrophobic interactions, steric hindrance, Van Der Walls forces and 
hydrodynamic forces. The longevity of this first adhesion will depend on the sum of these 
variables and also on the presence of organic substrates near to the surface, since 
microorganisms tend to aggregate in nutrient-rich environments. In the second stage, which is 
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considered irreversible, molecular reactions between bacterial surface structures and substratum 
surfaces are enhanced. This implies a tighter adhesion of bacteria to a surface by the bridging 
function of bacterial surface polymeric structures. The microorganisms will bind to the surface 
by the production of exo-polysaccharides and or specific attachment structures such as pili or 
fimbriae. After this stage, a much stronger physical or chemical agent is necessary to detach the 
cells. When the microorganism is irreversibly attached, the biofilm maturation begins. During 
the maturation, its density and complexity increase, the organisms start to replicate and 
producing extracellular components that will interact with the organic and inorganic molecules 
of the environment to create the extracellular polymeric matrix (EPS).59,68 The micro-colony 
formation will occur with the clonal growth of the adherent cells and the micro-colonies will 
grow forming the macro-colonies.  Finally, in the last dispersal step, the macrocolonies can 
release cells from the biofilm that will return to the planktonic form to eventually initiate the 
colonization of a different microhabitat.67 
Biofilms are known to be structurally heterogeneous, consisting of a complex matrix, which is 
the major part (around 97% of the biofilm), composed by water and extracellular substances 
like polysaccharides and proteins, and cell clutters formed by microorganisms of the same 
species or a mixture of different microorganisms.69,70 It is well known that each of the 
components plays an important role in the biofilm formation and maintenance. For example 
water is required for processes of diffusion into and within the biofilms, cell clusters will 
produce the EPS matrix and signalling molecules that are important for cell-cell communication 
(quorum sensing) and EPS will play a role in the architecture and maintenance of the biofilms 
structure. 
The extracellular polymeric substances include polysaccharides (mainly hexoses and pentoses) 
which are actually major components of the biofilm matrix.71 The matrix also contains proteins, 
nucleic acids (DNA and RNA), lipids, heteropolymers and humic substances.72 
The EPS contribute for the formation and maintenance of biofilm structure, and the morphology 
of the colonies is more affected by the capacity of the cells to produce EPS.73 
The biofilm EPS play a role in the determination of the strength, elasticity and adsorption 
capacity of the biofilms. It confers physical/chemical protection, facilitates metabolic 
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interactions between cells, works as a supply of substrates for growth and acts as a protective 
mechanism against desiccation and toxic substances, such as biocides and antibiotics.72,74  
The transition from the planktonic to the sessile form involves a phenotypic change determined 
by a shift in gene expression which in term, is triggered by cell to cell communication 
mechanisms. 
Quorum sensing (QS) is a density-dependent form of cell-cell chemical communication trough 
signal molecules.75 Microorganism can use QS to coordinate for example the formation of 
biofilms, swarming and the production of polysaccharides.76 
The cell-cell communication underlies the triggering and reinforcement of common group 
responses during biofilm formation. This, communication is regulated by signalling molecules 
that are released by some cells, and detected and perceived by other cells and also by producer 
cell.67,75 At certain concentrations they can trigger the expression of multiple genes that regulate 
important biological functions such as transfer of plasmids, mobility, aggregation, 
luminescence, biosynthesis of antibiotics, expression of virulence factors, symbiosis, and 
development of the biofilm.77  
 
1.2.2.2. Biofilm resistance 
Microorganisms organized in biofilms are more resistant to antimicrobials than the planktonic 
form. This resistance is provided by different defense mechanisms that have been developed by 
biofilms. The EPS matrix constitutes one of the principal barriers, by preventing the penetration 
of antimicrobials into the biofilms.78  Several studies have demonstrated the difficulty of many 
antibiotics to diffuse into biofilms, suggesting that the antibiotics bind to the EPS, being thereby 
retained in the extracellular matrix, which prevents of reaching the cells within the biofilm. Not 
only the inhibition of diffusion is involved in the antibiotic resistance, but the production of 
enzymes that catalyze antibiotics activity, or the matrix charge can also play a role, through the 
inhibition of drug activity or by retarding the penetration providing more time to develop 
resistance.78,79 The grow rate can influence the susceptibility of biofilms to antimicrobials. It is 
known that the slow growth of cells in mature biofilms increases the resistance due to increased 
cell density.78 The activation of stress responses by biofilms in order to fight external agents is 
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very common. These stress responses result in the physiological changes or in the production of 
enzymes or toxins to protect from anti-microbial agents.78,80 QS will mediate the activation of 
these stress responses, by the production of interacting signals ,which allows the 
microorganisms to sense when there is a limitation of cells in the environment and expresses 
the genes to  inhibit the effect of the antibiotics.79,80 The existence of persistent cells, that can 
be found either in planktonic or biofilm communities is one of the reasons of antimicrobial 
resistance.81 However it is more frequent to find persistent cells in biofilms than planktonic 
communities, which may be other explanation for the lower susceptibly of biofilms are 
antibiotics.82 
 
1.2.2.3. Negative impact of biofilms 
 
Biofilms are found in different areas of industry, environment and health. Their presence may 
have beneficial or detrimental impacts, depending on the characteristics and functions of the 
organisms and of the attaching surface, but very often biofilms development is associated with 
chronic infection, biodeterioration and biocorrosion with significant human and economic 
losses. 
Biofouling refers to the undesired accumulation of microbial and extracellular material of 
microorganisms on surfaces that causes deterioration of materials and affects the efficiency of 
several processes which those surfaces are involved.83 This phenomenon can occur in several 
situations like the dental plaque, the colonization of medical devices, the deterioration of metal 
surfaces such as in ship hulls and buildings, in pipelines and industrial structures.56  In industries, 
biofouling is a major concern due to the metallic corrosion affects. Water cooling systems, 
increases the resistance to heat energy transfer and increases fluid frictional resistance when 
film thickness surpasses the monolayer.84 In membrane systems, the attachment of 
microorganisms can lead to the decrease the membrane flux and increase filtration pressure and 
thus demand for the frequent cleaning and replacement of the equipments.76 In buildings, 
biofouling in walls can influence the heat uptake and so the energy demands inside the building. 
In ships it leads to reduction in speed, increase the fuel consumption or even enhance the 
corrosion of the hulls.56 All these problems will conduce to loss of energy, increasing of costs 
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and loss of quality in the final products. Beside all the environmental issues caused by biofilms, 
they are also involved in several human infections, being responsible for over 60% of infections 
caused by bacteria. Biofilms are responsible for several human infections, among which 
periodontitis, cystic fibrosis pneumonia, chronic urinary tract infection, tonsillitis, 
rhinosinusitis, otitis media, wound infections, infectious kidney stones, bacterial prostatitis, etc. 
Beside this, they can also associated to medical devices causing serious infection.79,85 
 
1.2.2.4. Inactivation of biofilms 
Because of these impacts, environmentally sustainable and cost-effective approaches for biofilm 
control or inactivation are urgently needed. To minimize the losses caused by the attachment of 
microorganisms to the surfaces and overcome their intristic and acquired resistance, some 
alternatives have been attempted, such as the modification of nature of the solid surface, 
optimization of operation conditions, physical and chemical cleaning, use of biocides, synthetic 
dispersant or enzymes.76,84 Although traditional chemical methods still the most commonly 
used, new alternatives are being introduced. One example is photodynamic inactivation (PDI) 
that proved to be an economic, environment-friendly approach to biofouling problems.24 
PDI is widely investigated as a therapeutic alternative for biofilms infections, since it is a 
multitarget process and there is a lack of antimicrobial resistance. PS used in PDI present high 
reactivity and this allow interactions either with cellular and non-cellular biomolecules, which 
for the inactivation of biofilms is an important advantage since their extracellular matrix are 
equally susceptible to the photosensitizing effect.86 It is expected for biofilms to be more 
resistant to PDI than planktonic cells and in fact they are. However it was demonstrated that the 
increasing of the light dose, time exposure or PS concentration will lead to higher PDI efficiency 
in biofilms.87–89  
Many PS have been reported as efficient drugs for the photodynamic inactivation of biofilms, 
namely methylene blue and toluidine blue O, considered effective PS to treat oral and medical 
infection caused by biofilms.90,91 Beside these two dyes, macrocyclic photosensitizers like 
phthalocyanines, porphyrins and chlorines are used in PDI of attached microorganisms 
Reductions of 4 and 3 log on the concentration of surviving Pseudomonas aeruginosa  and 
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Streptococus epidermis wre observed with Tetra-Py+-Me and Tri-Py+-C14-Py
+-Me but this PS 
have the inconvenient of presenting dark toxicity, reductions of 6.5, 6.3 and 2.8 log of Candida 
albicans, Staphylococcus aureus and Pseudomonas aeruginosa, respectively.6,88 Zinc- 
phthalocyanines have been also reported as efficient PS against biofilms. A study of 
photodynamic inactivation with Zn(II) Pc reported the destruction of  dental-plaque biofilms.92 
The fungus Candida albicans  can be completely inactivated with Si(IV) phthalocyanine 
derivative under soft condition.93 
 
1.2.3.  Bioluminescence as reporter for photodynamic inactivation assays 
Bioluminescence is considered a fast and effective method to monitor the photodynamic 
inactivation of microorganisms. It can be used in direct, continuous and non-destructive 
approaches to follow the inactivation processes in real time.94 
The bioluminescence method consists in a process in which organisms produce light by 
reactions that involve consumption of energy and that are tightly related to the metabolic activity 
of the cell. These reactions are catalysed by luciferases.95,96 
Different bacteria are able to produce light and they can be found in terrestrial, freshwater and 
marine environments. All bioluminescent bacteria are classified as Gram-negative and normally 
they are included in one of the genders: Vibrio, Photobacterium and Photorhabdus (formerlly 
Xenorhabdus), that are naturally light producers.94 The luciferase gene is now well characterized 
and cloned, which allows bacteria that are not natural light-emitting organisms to emit light. 
Normally, the transformed bacteria are Gram negative, such as Escherichia coli. 
In bacteria, the light emitting reaction consists in the oxidation of fatty aldehyde and riboflavin 
phosphate FHNH2 with emission of light.
97 
The most common methods used to follow infections require several steps, for example to 
follow animal infections it is necessary to sacrifice the animal, remove the infected tissue, 
homogenise, make serial dilutions, plate and count the colonies.49 By using bioluminescence, a 
directed correlation between viable cells and the emission of light can be established, since only 
active cells can be detected. Therefore, a decrease in bacteria bioluminescence reflects a 
decrease in the number of active cells or a decrease in the average level of activity of the 
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population.98 In the beginning of the year 2000, bioluminescent bacteria started to be used and 
it proved to be more effective, simpler, faster and sensitive than conventional plating methods 
to make the screening of viable bacteria after PDI exposure. Since then, this approach has been 
widely used to do the screening of effective PS used to inhibit the growth of the bacteria and its 
bioluminescence.94 In addition to these advantages, another advantage is that different than other 
chemicals, the PS  does not interfere with the bioluminescence of the microorganism.94  
Bioluminescence method was also considered an efficient method to monitor the photodynamic 
inactivation of biofilms infections.99,100 The possibility to use this method seems to overcome 
one of the major problems pointed for the traditional techniques that is the extraction of bacteria 
from the surface.101 Light emission of biofilms tends to be lower than in planktonic cells, due to 
nutrient starvation and oxygen availability which reduce power of bioluminescence.101,102 
However, this does not affect the number of viable cells, thus it important to establish a non-
luminescent end point in the PDI process. 
 
1.3.  Objectives  
The aim of this work was to produce new water-soluble zinc-phthalocyanine for the control of 
bacteria, either in the planktonic or in the biofilm forms. For that, a zinc-phthalocyanine with 
peripheral substitution with cysteamine hydrochloride was synthesized and characterized by 
spectroscopic methods. Further photophysic studies of this compound and other phthalocyanine 
derivatives, that were previously synthesized and characterized, were conducted in order to 
assess their potential as photosensitizers for inactivation of microorganisms. After the initial 
screening with a rapid bioluminescence test based on planktonic cells of a recombinant strain of 
Escherichia coli, selected phthalocyanines were tested against biofilm prepared with the same 
strain.   
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2.1.  Synthesis optimization 
2.1.1. Synthesis of thiocysteamine phthalonitriles 
For the synthesis of new cationic zinc-phthalocyanines different synthetic methodologies were 
followed. In an initial phase, we tried to obtain new phthalocyanine derivatives containing 
cysteamine units at the peripheral positions. To obtain these molecules, the synthetic route was 
divided into three steps: (i) synthesis of mono and di-substituted cysteamine phthalonitrile 
derivatives; (ii) cyclic tetramerization of phthalonitriles to corresponding 
Zn(II)phthalocyanines; (iii) protection and deprotection of  Zn(II)phthalocyanines.   
 4-thiocysteaminesubstituted phthalonitrile, 7, (Scheme 3) was obtained by nucleophilic 
substitution reaction. 4-nitrophtalonitre (5.75 mmol) reacted with cysteamine hydrochloric acid 
(1.43 mmol) in presence of potassium carbonate (K2CO3) (1.54 mmol). The reaction mixture 
was kept at 50 ºC and under stirring. After 24 hours, the reaction was stopped, distilled water 
were added. The formed precipitate was filtered and washed with dichloromethane and water to 
remove unreacted starting materials if any. It was not possible to proceed for further 
purifications because the obtained powder was not soluble in any of the regular solvents. The 
powder was dried and submitted to NMR and mass spectrometry, but the results were 
inconclusive. 
 
 
 
 
Scheme 3 
 
To obtain the di-substituted phthalonitrile with cysteamine, compound 8, (Scheme 4) 0.51 mmol 
of 4,5-dichlorophtalonitre was reacted with 1.22 mmol of cysteamine hydrochloric acid in 
presence of 1.09 mmol of K2CO3. The reaction mixture was kept at room temperature and under 
stirring. After 2 hours, the reaction was stopped and distilled water was added. The formed 
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precipitate was filtered and washed with water and dried. The TLC showed the presence of small 
amounts of starting material along with two other products with close separation between them. 
Therefore, in order to separate the two products, it was necessary to prepare TLC plates using 
dichloromethane (DCM) with 15% of methanol as eluent. The product was separated from the 
silica by filtration and later dried. Further, the compound was characterized by 1H NMR, FT-
IR, and mass spectroscopic techniques, but the results were still inconclusive. 
 
 
Scheme 4  
 
2.1.2.  Synthesis of (octakis[4,5-bis[thiocysteamine]phthalocyaninato])zinc(II) 
Since the synthesis/characterization of the thiocysteaminephthalocyanine using the 
corresponding phthalonitriles revealed to be difficult, new approaches for the synthesis were 
attempted. In the new synthetic rout, the objective was to obtain the phthalocyanine as starting 
material.  For that, a reaction with 1.01 mmol (200 mg) of 4,5-dichlorophthalonitrile and 0.5 
mmol (681 mg) anhydrous zinc chloride  under nitrogen atmosphere and reflux conditions was 
conducted. After 24 hours the reaction was stopped and petroleum ether was added to dissolve 
the crude material. The product was precipitated and re-precipitated in methanol.  
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Scheme 5 
 
After having the phthalocyanine 9, the synthesis of the thiocysteamine substituted, Pc 10, by 
reacting the compound 10 with cysteamine hydrochloride was attempted in order to get 
peripheral substitutions (Scheme 5). For this, 50 mg ZnPc 10 reacted with 70 mg cysteamine 
hydrochloride acid using DMF as solvent and K2CO3 as base. The reaction was kept at room 
temperature and nitrogen reflux for 24 hours. The reaction could not be controlled by TLC since 
the starting material did not move in the TLC plate. 
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2.1.3. Synthesis of aminoethylcarbamate phthalonitriles 
Following all the unsuccessful attempts to obtain phthalonitriles or a phthalocyanine substituted 
with thiocysteamine groups, a different substituent containing amine groups connected by an 
alkyl spacer was used. The objective was to introduce a protected amine group in the 
phthalonitrile, and then, to perform the cyclotetramerization of the phthalonitrile, the hydrolysis 
and finally the cationization of the phthalocyanine.   
 
The phthalonitrile 11 (Scheme 6) was synthesized by reacting the 4-fluorophthalonitrile (0.6 
mmol) with tert-butyl(2-aminoethyl)carbamate (1.03 mmol) using DMF as solvent and K2CO3 
as base. The reaction was stirred under nitrogen atmosphere and at room temperature. The 
progress of the reaction was monitored by TLC. After 2 hours, the TLC revealed the appearance 
of two spots, one of which was identified as starting material and the other indicating the 
formation of the product. We further extended the reaction for 24 hours, but reaction was not 
was not complete. Because of this, we decided to keep the reaction at 50 ºC for more 2 hours. 
However, no change was observed in the progression of the reaction, so we stopped the reaction. 
Distilled water was added to the reaction mixture and extracted with dichloromethane. The 
organic layer was collected and the solvent was evaporated under reduced pressure. 
Tetrahydrofuran was added and evaporated in order to remove some remaining DMF. The 
product was purified by column chromatography using silica gel as stationary phase, 
dichloromethane/hexane (9:1) and then dichloromethane/methanol (98:2) as eluents (yield 
55%). The product fraction was characterized by 1H NMR and mass spectrometry.  
 
 
Scheme 6 
 
1H NMR spectrum of compound 11 (Figure 8) showed one doublet at δ 7.67 ppm and one 
multiplet at δ 6.90-6.94 ppm, corresponding to the protons of benzene ring at 5, 6 and 3 
positions; one triplet and one doublet at δ 7.13 and δ 7.29 ppm, referring to the aliphatic protons; 
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two double doublets at δ 3.07 and δ 3.20 ppm related to the protons of alkyl chain and one 
singlet at δ 1.36 ppm, due to the resonances of the CH3 protons. 13C spectrum show 10 signals, 
in which 3 corresponded to the carbons in benzene ring, 1 corresponded to cyanine groups and 
the others are referent to the methyl, ethyl, carbonyl groups (Figure 9). 
 
 
Figure 8- 1H NMR (300 MHz) spectra of the phthalonitrile 11 in DMSO-de 
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Figure 9- 13C NMR (125.77 MHz) spectra of the phthalonitrile 11 in DMSO-d6 
 
Phthalonitrile 12 (Scheme 7) was obtained from reaction of 4,5-flourphthalonitrile (0.6 mmol) 
and tert-butyl(2-aminoethyl)carbamate (1.4 mmol) in presence of DMF and K2CO3. The reaction 
mixture was kept overnight stirring, under nitrogen atmosphere and at room temperature. After 
this period, the TLC revealed that the reaction was complete. The reaction mixture was extracted 
using distilled water and dichloromethane. The organic layer was evaporated under vacuum. 
Toluene was added and evaporated in order to remove some remaining DMF. This product was 
precipitated with hexane and dichloromethane and dried under vacuum. 1H NMR confirmed the 
proposed structure of di-substituted phthalonitrile 12, yielding 63%. 
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Scheme 7 
 
 
1H NMR spectrum (Figure 10) shows two doublets at δ 7.86 and δ 7.40 ppm, corresponding to 
the protons of benzene ring at positions 3 and 6; one doublet at δ 7.15 and one triplet at δ 6.91 
referring to the resonances of the aliphatic protons; two double doublet at δ 3.11 and δ 3.26 ppm, 
corresponding to the protons 3 and 2, respectively; one mutiplet at δ 1.37 ppm, referring to the 
resonances of the methyl protons. Due to the symmetry of the phthalonitrile, the 13C NMR 
spectrum showed 8 signals, each one corresponding to 2 carbons from a total of 16 carbons 
(Figure 11). 
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Figure 10-
1
H NMR (300 MHz) spectra of phthalonitrile 12 in DMSO-d6 
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Figure 11- 13C NMR (125.77 MHz) spectra of the phthalonitrile 12 in DMSO-d6. 
 
 
 
2.1.4. Synthesis of [tert-butyl(amino)carbamate]phthalocyaninato)zinc(II) 
Pc 13 (Scheme 8) was synthesized by cyclotetramerization of phthalonitrile 11 (0.51 mmol) 
with anhydrous zinc chloride (0.30 mmol) in presence of DMAE (1 mL). The reaction was kept 
overnight stirring at 130 ºC. After this time the TLC revealed that the reaction was complete, 
the crude product was precipitated with hexane and ethyl acetate and filtered under vacuum. 
The filtrated was purified by column chromatography with silica gel as stationary phase and 
dichloromethane: methanol (8:2) as eluent. 
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Scheme 8 
 
Pc 14 (Scheme 8) was obtained from the cyclotetramerization of phthalonitrile 12 (0.32 mmol) 
with anhydrous zinc chloride (0.26 mmol) in the presence of DMAE (1 mL). The reaction was 
kept overnight with stirring and under 130 ºC. After this time the TLC revealed that the reaction 
was complete. The crude product was precipitated with hexane and ethyl acetate and filtered 
under vacuum. The filtrated was purified by column chromatography with silica gel as 
stationary phase and dichloromethane: acetone as eluent. The phthalocyanine was obtained in 
6% yield. 
 
Scheme 9 
 
The structure of Pc 14 was confirmed by the 1H NMR. 1H NMR spectrum showed three 
multiplets, one corresponding to the resonances of the α protons of the macrocycle at δ 8.96-
8.99; δ 8.88-8.91; δ 8.55-8.76 other at δ 7.24-7.29; δ 6.41-6.96 corresponding to the aliphatic 
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protons and the other at δ 1.31-1.56 referring to the methyl protons of Boc group. The signal of 
protons in the alkyl groups was overlapped by the solvent signal. (Figure 12).   
 
 
 
 
 
Figure 12-1H NMR (300 MHz) spectra of the hthalocianine 14 in DMSO-d6 
 
 
 
 
 
After performing the synthesis of the phthalocyanine 14, the following step was the hydrolyze 
of the Boc groups. For this, a reaction mixture of compound 14, 1.35 mmol, and 1 mL of 
hydrochloride acid was kept at 80 ºC and stirring during 5 hours. The TLC revealed that the 
starting material was completely reacted and a new product was formed. The hydrochloride acid 
was removed by filtration and the filtrated was washed with acetone (Scheme 10). 
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scheme 10 
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2.2.  Experimental procedures. 
Tert-butyl(3-amino)ethyl)carbamatephthalonitrile (11):  4-fluorophthalonitrile (0.84 
mmol), tert-butyl (2-aminoethyl)carbamate (1.3 mmol) and dry K2CO3 (1.08 mmol) was added 
in 3 mL of DMF. The mixture was kept with stirring under nitrogen atmosphere and at room 
temperature for 24 hours. After this time, distilled water was added to the reaction mixture and 
extracted with dichloromethane. The organic layer was evaporated under reduced pressure. The 
product was purified by column chromatography with silica as stationary phase and CH2Cl2- 
MeOH (9.8:0.2). The product was dried under vacuum. 1H NMR (300 MHz, DMSO-d6, ppm): 
δ 7.7 (d, J =9, 1H), 7.3(t, J = 12, 1H, NH), 7.1 (d, J= 3, 1H, NH), 6.90-6.94 (m, 2H), 3.1 (dd, 
J=12 and 24 , 2H, CH2), 3.2 (dd, J= 12 and 24, 2H, CH2), 1.4 (s, 9H, CH3). 
13C NMR (125.77 
MHz, DMSO, ppm): δ 27.9, 41.7, 77.7, 97.5, 115.6, 116.5, 117.5, 134.7, 151.7, 155.7. ESI_MS 
calculated for C15H18N4O2: 286.33 found: 327.1 [M+H]
+. 
 
Ditert-butyl(bis(ethane-2,1-diyl))dicarbamate phthalonitrile (12): 4,5-
diflourophthalonitrile (0.61mmol), tert-butyl(2-aminoethyl)carbamate (1.33 mmol), K2CO3 
(0.88 mmol) was dissolved in 3 mL of DMF. The reaction mixture was left with uniform stirring 
under nitrogen atmosphere and at room temperature, overnight. The completion of the reaction 
was monitored by TLC. Distilled water was added to the reaction mixture and extracted with 
dichloromethane. Residual DMF was removed with the addition of toluene. The compound was 
further purified by column chromatography over silica gel with dichloromethane: methanol 
(9.8:0.2).  1H NMR (300 MHz, DMSO-d6, ppm): δ 7,9 (d, J =24, 2H), 7.4 (d, J =18, 2H), 7.2 (s, 
2H, NH), 6.93 (t, J = 12, 2H, NH), 3.3 (m, 4H, CH2), 3.1 (dd, J= 12 and 24, 4H, CH2), 1.4 (m, 
18H, CH3), 
13C NMR (125.77 MHz, DMSO, ppm): δ 28.3, 42.0, 77.9, 97.7, 112.5, 115.0, 115.5, 
116.5, 119.0, 119.3, 141.6, 149.3, 152.6, 155.6 
2,3,9,10,16,17,23,24-octakis(ditert-butyl(bis(ethane-2,1-diyl))dicarbamate) 
phthalocyaninato)zinc(II) (14):  
A reaction mixture of 0.32 mmol of phthalonitrile 11 and 0.26 mmol of anhydrous zinc chloride 
was kept under stirring and at 130 ºC in 3 mL of DMAE overnight. The reaction was stopped 
and the product was washed with hexane and precipitated with hexane and ethyl acetate. The 
product was purified by column chromatography over silica gel and dichloromethane: acetone 
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as eluent. 1H NMR (300 MHz, DMSO, ppm): δ 8.96-8.96; 8.88-8.91; 8.88; 8.55-8.76 (m, 8H, β-
H) δ 7.24-7.29; 6.41-6.98 (m, 15H, NH) δ 1.31-1.56 (m, 72H, CH3) 13C NMR (125.77 MHz, 
DMSO, ppm) 
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Chapter 3 – Photochemical, Photophysical and 
Photobiologycal studies  
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3.1. Experimental procedure of photophysical and photochemical studies 
3.1.1.  Photosensitizers 
The photodynamic studies were carried out using six new cationic phthalocyanine derivatives 
(Figure 13).  A stock solution for each compound was prepared at a concentration of 500 µM in 
DMSO. All phthalocyanines included in this study, namely those produced in previous work 
and for which the synthesis is not described, were synthesized by the Organic Chemistry group 
of University of Aveiro (QOPNA) 
 
 
Figure 13 – Structure of photosensitizers used on the photodynamic studies 
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3.1.2. Fluorescence quantum yield 
The fluorescence quantum yields of the six phthalocyanines in DMF were measured in 1 x 1 cm 
quartz optical cells under room temperature on a spectrofluorimeter Fluromax 3 (Horiba Jovin 
Yvon). The fluorescence quantum yield of each phthalocyanine were calculated by the 
comparison of the area of the emission bands by comparison of the area below the corrected 
emission spectrum of the ZnPc, used as fluorescence standard at λexc=630 nm with Фf= 0.2 in 
DMF. In all cases, the absorbance of samples was kept at 0.2 at 630 nm, excitation 
wavelength.103 The fluorescence quantum yields were calculated according to the equation 
below (Equation1), 
 
Equation 1 
in which the AUC is the integrated area under the fluorescence curves of the phthalocyanines 
and Abs the absorbance of sample and standard at excitation wavelength. 
 
 
3.1.3. Solubility 
The solubility of cationic phthalocyanines derivatives 1-6 in PBS and DMSO was assessed by 
UV-visible spectroscopy. Concentration, between 2.0 and 20 µM, obtained by addition of 
aliquots of each phthalocyanine. UV-visible spectra were determined 5 min after the addition. 
The intensity of the Q-band versus phthalocyanine concentration was plotted in a graphic for 
linear regression to verify the compliance with Beer-Lambert law. 
 
3.1.4. Singlet oxygen generation  
The ability of the Pc to generate singlet oxygen was assessed by the qualitative method of 1,3-
diphenylisobensofuran (DPBF). 
A stock solution of DPBF at 10.0 mM in DMF/Water (9:1) and stock solution of each 
phthalocyanine at 500 µM were used. The reaction mixture of 50 µM of DPBF and 0.5 µM of 
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each phthalocyanine in DMF/water (9:1) were irradiated with LED at a Fluency rate of 9.0 mW 
cm-2, in glass cuvettes under magnetic stirring, at room temperature. The absorption decay of 
the DPBF at 414nm was measured at 3 minutes intervals during a total irradiation time of 15 
min. The percentage of DPBF absorption decay, proportional to 1O2 production, was assessed 
by the difference between the initial absorbance and the absorbance after the irradiation time.104 
 
3.1.5. Photostability and stability  
To study the photostability of the photosensitizers, each Pc was diluted in 2 mL of PBS to a 
concentration of 20 µM, and irradiated at same conditions used in the biological studies (150 
mW cm-2). The Pc were irradiated during 30 minutes under magnetic stirring at room 
temperature. The UV-visible spectra were collected at 5 minutes intervals during the irradiation 
in order to assess the the photostability of Pc. The photostability was assessed by monitoring 
the intensity of the Q band at the different time intervals. At same time, stability studies were 
carried out by irradiating the PS, protected from light by aluminium foil and under same 
conditions. The photostability and stability assays of each Pc were carried out at the same time 
and the percentage of decay was calculated according to It/I0 (%), where It is the intensity of the 
band at a given time and I0 is the intensity of the band before irradiation. 
 
3.2. Photodynamic inactivation assays 
3.2.1. Bacterial biological model 
For the photodynamic inactivation assays a recombinant bioluminescent strain of E. coli was 
used, it was obtained from a previous work.105 Before the assays a fresh liquid culture of the 
bacteria was prepared in medium containing the antibiotics, ampicillin (100 mg mL-1) and 
chloramphenicol (25 mg mL-1). To prepare the culture, the antibiotics were aseptically added to 
30 mL of a Tryptic Soy Broth medium (TSB; Liofilchem), and one aliquot of 240 μL of culture 
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was inoculated. The culture was grown at 25 ºC for 20 hours.This culture was used for the 
asssays of photodynamic inactivation of planktonic cells. 
3.2.2. Preparation of biofilms 
For the preparation of the E. coli biofilms to be used in photodynamic inactivation, a fresh liquid 
culture of the recombinant E.coli was grown overnight in TSB medium with the antibiotics, 
ampicillin (100 mg mL-1) and chloramphenicol (25 mg mL-1), at 150 rpm and 26 ºC. An aliquot 
(1.0 mL) of this culture was aseptically transferred to 30 mL of a medium containing casamino 
acid (1.0%), yeast extract (0.12%) ampicillin (100 mg mL-1) and chloramphenicol (25 mg mL-
1). Aliquots of 1.5 mL were distributed by eppendorf microtubes and incubated at 26 ºC. After 
24 hours of incubation the medium was discarded and fresh medium was added to the biofilms 
which were further incubated for 4 days at 26 ºC. 
3.2.3. Relation between bioluminescence and colony forming units 
To establish the correlation between light emission, expressed in relative light units (RLU) and 
the concentration colony forming units (CFU),  a culture of bioluminescent E.coli was grown 
overnight, and serially diluted (10-1 to 10-7) in  phosphate buffered saline (PBS) buffered. The 
luminescence was measured in each dilution and an aliquot of each dilution was sireally diluted 
and pour-plated in triplicate in Tryptic Soy Agar (TSA). The plates were incubated at 37 ºC 
during 24 hours and colonies were counted in the most suitable dilutions for the calculation of 
the concentration of colony forming units (CFU mL-1) in the cell suspension. 
 
3.2.4. Experimental set up for the photodynamic inactivation of planktonic cells 
Bacterial cultures grown overnight were 10-fold diluted in PBS to a final concentration 
corresponding to 107 CFU mL-1and kept under stirring at room temperature for 10 min. This 
bacterial suspension was equally distributed in 12-well plates and appropriate quantities of the 
three stock solutions of phthalocyanine derivatives (500 µmol.L-1) were added to achieve a final 
concentration of 20 µM in a total volume of 4.5 mL of cell suspension. The samples were protect 
from light with aluminium foil and incubated for 15 min under stirring, at room temperature, to 
promote PS binding to the cells. Light and dark controls were included in the experiment. Light 
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control was irradiated without the phthalocyanine and the dark control, containing 20 µM was 
protected from light with aluminium foil during the course of the experiment. Three independent 
assays were carried out for each compound. 
 
3.2.5. Experimental set up for the photodynamic inactivation of biofilms 
The liquid medium in the tubes containing the biofilms was discarded and replaced by an equal 
volume of PBS, and the biofilms were allowed to stabilize for 10 minutes. After this time, the 
Pc solution was added and the suspensions were incubated for 15 minutes, in the dark to promote 
the PS adsorption. The biofilms immobilized in the microtubes were irradiated with red light. 
Light and dark controls were included in the experiments. Light and the dark controls, were 
included in the experiment. Three independent assays were carried out for each compound. In 
these experiments two different conditions were used, irradiation with 20 µM and 40 µM of Pc, 
during 30 and 60 minutes, respectively.  
Irradiation conditions 
For the irradiation of the samples with red light (620-750) or white light (400-800), light was 
delivered by an illumination system (LC-122-LumaCare, London) containing a Halogen/quartz 
250 W lamp coupled to different interchanges optic fibber probes (620-750 nm and 400-800 
nm).The light was delivered at a fluency rate of 150 mW cm-2, measured with a potentiometer 
Coherent FieldMaxII-Top combined with a Coherent PowerSens PS19Q energy sensor. The 
samples were irradiated during 30 min under stirring and at room temperature for planktonic 
bacteria and 30 and 60 min without stirring for biofilm cultures. 
 Bioluminescence measurements 
The inactivation kinetics was followed by measuring the bioluminescence of the bacteria during 
the irradiation time. Aliquots of the samples and controls were collected at times 0, 5, 10, 15, 
20, 25 and 30 minutes for experiments with planktonic bacteria. Bioluminescence was read in 
triplicate in a luminometer (GLOMAXTM 20/20 Luminometer). In the experiments with 
biofilms, bioluminescence was read in triplicate in the luminometer after 0, 5, 10, 15, 20, 25 in 
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the first set of experiments with the lowest Pc concentration and after 30 minutes and 0, 10, 20, 
30, 40, 50 and 60 minutes for the experiments with the highest Pc concentration. 
3.2.6. Adsorption of the photosensitizers to planktonic cells 
 A bacterial suspension (107 CFU mL-1) was incubated in dark for 15 min in presence of 20 µM 
of the phthalocyanine derivatives (1-6), with magnetic stirring under room temperature for the 
binding of the PS to the cells. After this period, 1.0 mL of this suspension was centrifuged during 
15 min at 13 G in order to separate the cells from the PS solution. The supernatant was rejected 
and the pellet was washed with 1.0 mL PBS and centrifuged again, in order to further remove 
unbonded PS. The cells were digested with 1.0 mL of a solution containing 2% of dodecyl 
sodium sulphate (SDS) and 0.1 M of NaOH and the mixture was kept in the dark at 4 ºC at least 
24h until the clearance of the solution. The concentration of the PS in the digested extracts was 
determined by fluorescence. The samples were excited at 610 nm and emission spectra were 
collected in the 620-850 nm range. Fluorescence corresponding to the PS bound to the cells was 
calculated from the intensity of fluorescence by interpolation with a calibration plot build with 
known PS concentrations in the digestion solution. 
3.3. Results 
3.3.1.  Fluorescence quantum yield 
All the compounds emit fluorescence and the derivatives Pc4 and Pc5 have higher fluorescence 
quantum yield, followed by Pc2, Pc1, Pc3 and Pc6. (Table 2) 
 
Table 2 - Fluorescence quantum yields of compounds 1-6 in DMF using ZnPc at λext= 630 nm and Фf=0.2 nm. 
Compound Фf 
Pc1 0.01 
Pc2 0.02 
Pc3 0.005 
Pc4 0.37 
Pc5 0.39 
Pc6 0.001 
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3.3.2. Solubility  
 
The solubility of the six phthalocyanine derivatives (Pc 1-6) in DMSO and PBS at different 
concentrations was monitored by UV-visible spectroscopy. The results show two intense bands, 
corresponding to the soret and Q-band of the Pcs (Figure 14 and 15). The graphs obtained by 
plotting the Q band intensity of each Pc versus concentration show, that all the six compounds 
presented a linear regression in DMSO (Figures 14), which indicates that in this solvent they 
follow the Beer-Lambert law. The studies conducted in PBS show that all the Pcs also present 
linear regression, at the tested concentrations (Figure 15). 
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 Figure 14 - UV-visible spectra of Pcs 1-6 at different concentrations in DMSO. The linear regression graphics represent the Q-band absorbance 
of each Pc versus the concentrations in M. 
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Figure 15 - UV-visible spectra of Pcs 1-6 at different concentrations in PBS. The linear regression graphics represent the Q-band absorbance of 
each versus the concentrations in M. 
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3.7.2. Singlet oxygen generation 
The results obtained with the indirect method of 1,3-diphenylisobenzofuran show that all the 
phthalocyanine derivatives were able to generate singlet oxygen (1O2) causing the decay of 
absorbance of the DPBF. The cationic phthalocyanines presented better performance than the 
conjugated Pc, being the Pc4 and Pc5 the best 1O2 generators with an absorbance decay of DPBF 
higher than 90% after 15 min of irradiation (Figure 16). 
 
 
 
 
3.7.3. Photostability and stability 
The photostability studies with red light revealed that, with the exception of the Pc 3, 5 and 6 
all the others compounds, 1, 2 and 4 were photostable. Upon white light, the compounds showed 
to be photostable at the conditions that they were irradiated, however, the compound 5 revealed 
signs of photodegradation such as with red light. All the Pc were stable in absence of light. 
(Table 3) 
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Figure 16 - Singlet Oxygen generation of Pcs 1-6 assessed by the indirect method of 1,3-diphenylisobenzofuran 
DPBF (50 µM) in DMF/H2O (9:1) upon irradiation with white light with LED, at flounce rate of 9.0 mW cm2 
with or without Pc (05µM).Values correspond to average of two independent experiments. Error bars represent 
standard deviation of the mean. 
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Table 3 - Photostability and stability study of the Pcs 1-6 accessed by UV-visible spectroscopy after 30 minutes 
of irradiation under red and white light. 
Compound Phtotostability (%) 
Red light             White light 
Stability (%) 
Red light              White light 
Pc1 91.0 94.3 96.9 97.0 
Pc2 85.7 93.1 100 100 
Pc3 57.1 85.1 87.5 89.5 
Pc4 93.4 88.5 100 93.9 
Pc5 66.9 65.4 100 100 
Pc6 69.5 95.5 98.48 98.3 
 
 
 
 
 
 
3.7.4. Relation between bioluminescence and colony forming units  
The relation between the bioluminescence and the concentration of viable cells of E.coli, 
expressed in CFU mL-1 is represented in figure 17. The results show a significant linear 
correlation (R2=0.9414) between the light emission units and the colony counts. 
 
 
 
Figure 17 - Linear correlation between bioluminescence signal and colony counts of an overnight culture of 
bioluminescent E. coli serially diluted in PBS, with bioluminescence expressed in relative light units and colony 
counts expressed in CFU mL-1 
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3.7.5. Photodynamic inactivation of planktonic cells of bioluminescent E.coli 
The profiles of photodynamic inactivation of the bioluminescent E.coli strain using Pc 1-6, with 
red and white light are presented in Figures 18 and 19, respectively. 
The results obtained with both lights show that the PS did not present dark toxicity against 
bacterial strain in presence of 20.0 µM Pc, since the bioluminescence remained constant in dark 
controls. Also, direct cytotoxic effect triggered by light in absence of the PS (light controls) 
were not detected, since there was not a significant variation in light emissions variation during 
the experiments. Under red light, Pc 4 and 5 were the most efficient PS, causing reductions of 
approximately 4.0 log in light emission. Inactivation with Pc 1 and 3 was very small and the 
light emission was not different from the controls. With Pc 6, 2.0 log reduction in light emission 
was obtained. Upon irradiation with white light Pc 6 and 4 were more efficient in the 
photodynamic inactivation of the bacteria, causing a reduction of approximately 2.0 log 
followed by Pc 5 with a reductions of 1.5 log. Pc 1 and 3 did not significantly affect light 
emission. The comparison of both lights shows that with red light, a higher efficiency was 
achieved, particularty with Pc 4 and 5. However, under white light, inactivation efficiency 
decreased for all Pc, with exception of Pc 6, for which results were similar. 
  
Figure 18- Photodynamic inactivation of bioluminescent E. coli with Pc1-3 under red (A) and white (B) light at a 
fluency rate of 150 mW cm-2 in presence of 20 µM of each phthalocyanine. The error bars represent the standard 
deviation of three independent assays. 
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A B 
  
 
Figure 19- Photodynamic inactivation of bioluminescent E. coli with Pc 4-6 under red (A) and white (B) light at a 
fluence rate of 150 mW cm-2 presence of 20 µM of each phthalocyanine. The error bars represent standard deviation 
of three independent assays. 
 
3.7.6. Photodynamic inactivation of biofilms of bioluminescent E.coli  
The kinetics of photodynamic inactivation of biofilms by using the Pc 4 and 5 at a concentration 
of 20 µM and a fluency rate of 150 mW cm-2 under red light is represented in Figure 20-A . The 
bioluminescence of the biofilms was not affected neither during the irradiation in absence of the 
PS nor in dark with 20 µM of PS. Pc 4 was more efficient than Pc 5, causing a total reduction 
in the light emission of 2.3 log during 30 minutes of irradiation. The photodynamic inactivation 
with Pc 5, in the same conditions was less efficient with a decrease of only 1.8 log in light 
emission. During the first 15 minutes the redutions caused by the two Pc were similar, but after 
20 minutes of irradiation in presence Pc 4 the inactivation proceeded at slightly higher rate than 
with Pc 5. In the experiments conducted with higher PS concantration (40 µM, Figure 20-B), 
Pc 4 caused a reduction of 2.4 log in the biofilm light emission, and Pc 5 caused  a lower redution 
(1.5 log). At this concentration there was still not dark toxicity related to any of the tested Pc. 
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Figure 20- Photodynamic inactivation of bioluminescent E. coli biofilms with Pc 4 and 5 under red light at a 
fluency rate of 150 mw cm-2 presence of 20 µM (A) and 40 µM (B) of each phthalocyanine. The error bars represent 
the standard deviation of three independent assays. 
 
3.7.7. Adsorption of the photosensitizers to planktonic cells 
The results of the adsorption of each phthalocyanine derivative to E. coli cells after incubation 
in dark for 15 minutes are represented in Figure 21. Pc demonstrated highest affinity to the 
bacteria cells, with average uptake value of 1.11x109 molecules (PS) CFU-1. Pc 3, 4 and 5 
showed the lowest uptakes values ranging from 3.64x106 to 7.26x106 molecules (PS) CFU-1.  
 
Figure 21 - Uptake of the phthalocyanines 1-6 in the bioluminescent in presence of 20 µmol L-1 E.coli after 
15min of incubation in dark. Error bars represent the standard deviation. 
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4.1.  Discussion 
 
Considering the natural and the acquired resistance of microorganisms to the antimicrobial 
agents, particularly critical in the case of biofilms, there is an increasing interest on PDI as an 
alternative anti-microbial approach. In this work we aimed the design of new cationic 
phthalocyanines and the exploration of their potential as photosensitizers for the photodynamic 
inactivation of microorganisms, either in planktonic or in biofilm forms. 
Phthalocyanines bearing amino and alkyl groups have been widely investigated due to the 
interesting electronic properties conferred by these groups.  In this work we tried to obtain 
different alkylamino Pc by following different synthesis strategies. However, in our first attempt 
of introducing thiocysteamine groups by nucleophilic substitutions, either in phthalonitriles or 
in the octa-chlorophtalocyaninatozinc(II), we could not obtain the desired compounds. The 
compounds were not soluble in most regular solvents, most probably due the presence of the 
NH2 groups. In a new approach we could overcome the solubility problem by using a protected 
amino substituent, obtaining compounds with higher solubility. The synthesis method used to 
obtain phthalonitriles was very efficient resulting in a high yield of production for both 
phthalonitriles. From these phthalonitriles we were able to develop the conjugated Pc, although 
with low yield due to impurities in the compounds. 
The results of the biological assays conducted with the different phthalocyanines demonstrate 
that the molecules differ in the photosensitization efficiency of the bioluminescent E.coli.  Only 
two of the six studied Pc, 4 and 5, revealed potential for application in the PDI, at least under 
red light, since they caused significant inactivation of the E.coli survival (4 log reductions). 
Under white light, the reductions were generally smaller, being Pc 4 and 6 the most efficient in 
in the later conditions. 
The better performance of Pc 4 and 5 against a gram-negative model bacterium can be related 
to the physico-chemical properties of the molecules, namely in terms of solubility in aqueous 
medium and capacity to generate 1O2. These two Pcs showed to be the most efficient 
1O2 
generators, causing a decrease of over 90% in DPBF absorbance. The capacity to produce 1O2 
must be interpreted in the light of structure of the molecule and of other photophysical features. 
Pc 3 and 6 present broad Q-bands in DMSO, but in PBS the Q-bands are broader for all six Pc. 
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The variation of the Q-bands suggests that almost all Pc have monomeric behaviour in DMSO 
(1, 2, 4 and 5) and that all the Pc have non-monomeric behaviour in PBS. This tendency to form 
non-monomeric structures can affect the capacity of the Pc 1, 2, 3 and 6 to generate 1O2, since 
these structures tend to dissipate the energy of the excited states, thus compromising the PDI 
efficiency.106 Although, Pc 4 and 5 also have tendency to form non-monomeric structures in 
PBS, comparatively to the other Pc their Q-band is much intense, making them good singlet 
oxygen producers. The higher tendency of Pc 3 and 6 to form non-monomeric structures either 
in DMSO or in PBS, is due to the fluorine atoms in the macrocycles, leading to the formation 
of planar molecules with tendency to stack.  
The photosensitization potential of the different Pc may also be related with the number of 
charges the molecules. The results indicate that an increasing in the number of charges lead to 
an increase in the PDI efficiency, since Pc 1, 2, 3, tetra and octa-cationic Pcs, were less efficient 
than their conjugates, 4, 5, 6, octa- and hexadeca-cationic Pc. A relation between the number of 
charges and the photosensitization efficiency was reported with pyrrolidine-fused chlorins and 
isobacteriochlorines.107 However in another study comparing the inactivation efficiency of three 
cationic thio-pyridinium phthalocyanines showed that a higher number of positive charges had 
no effect on the PS efficiency.104 
The affinity of the PS by the cells can also play an important role in the PDI process, since for 
the photodynamic inactivation to occur, the PS must be close enough to the cellular target so 
that singlet oxygen may act within a very short time interval. However in this study we could 
not demonstrate a consistent relation between the amount of PS adsorbed and the efficiency of 
photodynamic inactivation. The most efficient PSs in terms of PDI did not correspond to the 
molecules with highest affinity to bacterial cells. Pc 2 showed a high uptake value but this can 
be an artefact due to its low solubility in the PBS medium and possibility of aggregation and 
precipitation on the call surface. Other studies, however, show that the antimicrobial PDI is not 
dependent on surface-bond PS but on permeation of the cell membrane by unbounded PS 
molecules.108 
 The comparison of the inactivation efficiency with white and red light reveals Pc 4 and 5 as 
particularly active under red light. The performance of Pc 1, 2, 3 and 6 did not change 
significantly the light wavelength range. The better results of Pc 5 with red light are likely due 
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to the higher overlapping of Q-band with the emission spectrum of the light source (Figure 22).  
The adjustment of the wavelength of the delivered light with the absorption spectrum of the PS 
is a major determinant of the outcome of the photodynamic effect. The same PS may 
considerably change in photodynamic inactivation efficiency depending on the light source, 
even if all other photodynamic parameters, namely PS concentration and fluency rate remain 
constant.12,104 The Q-band of Pc 4 shows higher overlapping with white light, however, 
inactivation was more efficient with red light. This is probably associated to the amount of 
photons adsorbed by the PS under red light, i.e., although the overlapping area is smaller the 
absorption rate of photons emitted by red light is enough to cause a higher photodynamic 
inactivation of the bacteria.  
  
 
Figure 22 - Normalized UV-Vis spectra of Pc 1-6 in PBS and white and red light source emission. 
 
One of the objectives of this study was to compare the inactivation efficiency of the 
photosensitizer against planktonic cells and biofilms. After doing the PDI studies with 
bioluminescent E.coli in the planktonic for and the selection of the most promising PS, the 
inactivation profile against bioluminescent E.coli in biofilm form was tested in similar 
irradiation conditions. Experiments with 20 µM of Pc achieved modest inactivation of 
approximately 2 log. In a second set of experiments, the PS concentration was doublet to 40 µM 
and the irradiation time was extended to 1 hour in the attempt of improving the inactivation 
efficiency. However, these modifications were not successful. This can be due to PS aggregation  
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observed when the PS concentration is high, causing a decrease in it molar absorbance at the 
wavelength absorption maximum.109  
Planktonic cells are more susceptible to photosensitization with Pc 4 and 5 than the biofilms. 
Beside the stronger reductions observed in the planktonic cell, we also notice that the 2 log 
reduction achieved in the biofilms experiments was achieved after 30 minutes of irradiation, 
while the same reduction was reached after 10 and 15 minutes of irradiation (Pc 4 and 5 
respectively) in the planktonic cells. Our results are consistent with others that observed higher 
reductions in the viability of the planktonic Staphylococcus aureus and Pseudomonas aruginosa 
than in the biofilm cells.87,88 Biofilms are imbedded in an extracellular polymeric matrix and the 
chemical composition of the matrix depending on the charge or  hydrophobicity, may decrease 
or increase the binding of the PS to the cells.110 In the case of E.coli biofilms, the extracellular 
matrix acted more like a barrier to the penetration of the PS than as trap for the PS making 
biofilm cells less susceptible to photosensitization. Biofilms present higher cell density 
comparing to planktonic cells. This may also explain the different results obtained in this study, 
since it is known that by increasing the cell number the amount of PS that bound to the cells 
will decrease.6 The interpretation of the results of the photodynamic inactivation of a 
bioluminescent biofilm must also take into consideration the conditions in which is produced in 
order to ensure that the reduction observed in the biofilms bioluminescence reflects a reduction 
in the number of viable cells. In future studies, the inactivation must be assessed by a non-
luminescent endpoint, such as plating and colony counting colonies. 
 
4.2. Conclusion 
 
In conclusion, new amino-phthalonitriles and their corresponding multi-amino Pc were 
synthesized, although not all could be fully characterized. The need of alternative treatments 
against bacterial resistance has led to find new approaches such as photodynamic inactivation 
of microorganisms. This strategy appears as an interesting alternative for the treatment of 
bacterial infections. For this purpose, new photosensitizers have been designed with improved 
physico-chemical properties that increase the efficiency and the possibility to inactivate a wide 
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range of microorganisms, and microbial biofilms. Pc 4 and 5 were efficient singlet oxygen 
producers and were soluble in organic and aqueous mediums while Pc 1, 2, 3 and 6 produced 
less singlet oxygen generators and were soluble in aqueous medium. This study demonstrates 
that the nature and number of substituents can strongly affect the singlet oxygen generation and 
solubility of the PS, and that the presence of fluorine groups in the macrocycle can diminish the 
photosensitizing effect of the PS.  
Biofilms still represent a challenge to photodynamic inactivation. However PDI experiment 
with the planktonic cells shows that two of the tested Pc may be promising photosensitizers for 
Gram-negative bacteria. The efficiency of the photodynamic inactivation process is determined 
by a combination of attributes like singlet oxygen, solubility in aqueous medium, wavelength 
absorption and also in the adjustment of the light to the absorption spectrum of the Pc. Pc 4 and 
5 may be considered promising photosensitizers to treat infections caused by Gram-negative 
E.coli, but for complete inactivation of biofilms infection repeated treatments may be required. 
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